HSBC plans 15-month AMPS with cap linked to basket of 20 stocks

By Wendy Van Sickle

Columbus, Ohio, Sept. 8 – HSBC USA Inc. plans to price 0% Accelerated Market Participation Securities due Dec. 14 2017 linked to an equally weighted basket of 20 common stocks, according to an FWP filing with the Securities and Exchange Commission.

The basket consists of the common stocks of American Airlines Group Inc., Allegiant Travel Co., Alaska Air Group, Inc., BioMarin Pharmaceutical Inc., Delta Air Lines, Inc., Gilead Sciences, Inc., Horizon Pharma plc, Intercept Pharmaceuticals, Inc., Intuitive Surgical, Inc., Jetblue Airways Corp., Kite Pharma, Inc., Southwest Airlines Co., Las Vegas Sands Corp., MGM Resorts International, Puma Biotechnology, Inc., Regeneron Pharmaceuticals, Inc., Seattle Genetics, Inc., United Continental Holdings, Inc., Vertex Pharmaceuticals Inc. and Wynn Resorts, Ltd.

The payout at maturity will be par plus triple any basket gain, up to a maximum of at least 23%. The exact cap will be set at pricing.

Investors will be fully exposed to any decline in the basket.

HSBC Securities (USA) Inc. is the agent.

The notes will price on Sept. 12 and settle on Sept. 14.

The Cusip number is 40433UVG8.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.